P125 A mixed methods feasibility study of a gait rehabilitation programme for people with early rheumatoid arthritis and foot pain

Hendry, GJ, Bearne, L, Foster, N, Godfrey, E, Hider, S, van der Leeden, M, Mason, H, McConnachie, A, McInnes, I, Patience, A, Sackley, C, Sekhon, M, Williams, AE ORCID: https://orcid.org/0000-0003-1224-4347, Woodburn, J and Steultjens, M 2020, P125 A mixed methods feasibility study of a gait rehabilitation programme for people with early rheumatoid arthritis and foot pain , in: British Society for Rheumatology Annual Conference 2020, Cancelled due to COVID-19 pandemic.

[img] PDF (Published Poster Abstract) - Published Version
Restricted to Repository staff only

Download (62kB) | Request a copy
Access Information: The above link directs to the journal website where this published Poster Presentation Abstract can be read for free.

Abstract

Background Foot pain, a hallmark feature of rheumatoid arthritis (RA), is associated with slow and unsteady gait patterns, and persistent walking disability is common. Great Strides is a new gait rehabilitation programme designed to improve/preserve lower limb function in early RA. It is delivered by physiotherapists or podiatrists over 12-weeks and is supplemented with a home programme and support materials (DVD and illustrated booklet). It consists of a 6-task gait circuit and is underpinned by behaviour change techniques driven by motivational interviewing. The aims of this feasibility study were to 1) evaluate patient acceptability, adherence to, and safety of Great Strides, and 2) identify a suitable primary outcome measure for the main trial.
Methods This study was a multi-centre (n = 3), single arm, repeated measures (pre- and post-intervention) design, with interviews exploring participants’ intervention perceptions. People with early (<2 years) RA who had foot pain were invited to participate. Intervention acceptability was evaluated using a 3-item intervention acceptability questionnaire. Adherence was evaluated using the Exercise Adherence Rating Scale (EARS). Safety was monitored using case report forms. Complementary mixed methods integrated descriptive quantitative acceptability, adherence, safety and thematic analyses to corroborate findings. Measurement properties of candidate primary outcomes (10-metre walking time, Foot Function Index disability subscale [FFI-DS], Recent Onset Arthritis Disability lower extremity subscale, and Patient-Reported Outcomes Measurement Information System physical function short-form) were evaluated against a 7-point Change in Walking Ability scale (CWA). Results 35 participants (68.6% female) with median age (inter-quartile range [IQR]) 60 [49-68] years and disease duration 9 [4-16] months), were recruited over 9 months and 23 (67%) completed 12-week follow-up. 12 participants completed interviews after the 12-week intervention period. Intervention acceptability was excellent; 21/23 were confident that it could help the problem; 21/23 reported that they would recommend it to a friend; 22/23 indicated it made sense to them. Intervention adherence was moderate, with a median [IQR] EARS score of 12/24 [7-19]. 1 participant reported transient post-exercise soreness. No serious adverse events were reported that were related to the intervention. From interviews, 10/12 participants reported they had continued with the intervention after 12-weeks. Participants revealed that the intervention provided structure and control to their day/week. Additional perceptions of benefit reported included improvements to lower limb joint health, and feelings of increased confidence to return to, or progress to further exercise in the community. The main challenge identified by some participants was lack of space to do the intervention at home. Correlations with the CWA were better for FFI-DS change-scores.
Conclusion Great Strides has excellent acceptability and appears safe for people with early RA. Levels of adherence may be improved by intervention refinement. FFI-DS scores were theoretically consistent for selection as primary outcome for the main trial.

Item Type: Conference or Workshop Item (Poster)
Additional Information: ** Article version: VoR ** From Crossref via Jisc Publications Router **Journal IDs: pissn 1462-0324; eissn 1462-0332 **History: published_online 20-04-2020; issued 01-04-2020; published 01-04-2020 **License for this article: starting on 01-04-2020, , https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
Uncontrolled Keywords: Pharmacology (medical), Rheumatology
Schools: Schools > School of Health and Society
Journal or Publication Title: Rheumatology
Publisher: Oxford University Press (OUP)
ISSN: 1462-0324
Related URLs:
SWORD Depositor: Publications Router
Depositing User: Publications Router
Date Deposited: 13 May 2020 09:19
Last Modified: 13 May 2020 09:30
URI: http://usir.salford.ac.uk/id/eprint/56940

Actions (login required)

Edit record (repository staff only) Edit record (repository staff only)

Downloads

Downloads per month over past year